Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA's Draft Track and Trace Guidance Is Too Late As Serialization Systems Are Already In Place - Industry

Executive Summary

The pharmaceutical industry sees many problems with US FDA’s draft guidance on product serialization to comply with the Drug Supply Chain Security Act of 2012, including requirements for “absolute uniformity.” Moreover, it’s coming out too late for companies that long ago set up serialization IT systems to comply with a November deadline.

Advertisement

Related Content

Gottlieb: FDA May View State Drug Wholesaler Licensure As Fully Preempted Under DSCSA
Track And Trace: Stakeholders Beg FDA For Early Guidance

Topics

Advertisement
UsernamePublicRestriction

Register

PS123218

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel